News Archive

April 2010	Judith Offman has joined CPTU as Study Co-ordinator for the FH01 blood study and Out of Hours study. Judith replaces Fiona Dungey.
November 2009	The CPTU, in conjunction with the Centre for Experimental Cancer Medicine, have set-up a patient and public advisory group. It is essential for our trials units to be able to gauge public opinion regarding both the information being provided to participants of clinical trials, and also on the principles and priorities that have inspired the proposed studies. The Queen Mary Trials Advisory Group (QMTAG) will assist the units by:- Providing feedback on trial design / research proposals. Reading and critiquing the patient documentation e.g. Patient Information Sheet, Consent Forms. Evaluating consent procedures. Representing the wider patient community by participating in meetings and discussion groups. Advising on how specific communities should be approached, and the need for trial-specific consumer groups.
September 2009	New content for FH01 and Out of Hours studies.
July 2009	Dr Fiona Dungey has joined CPTU as a Study Co-ordinator for the FH01 blood study and Out of Hours study.
April 2009	Following a successful review in November 2008, the CPTU has been awarded a renewed programme grant from Cancer Research UK starting 1st June 2009
March 2009	The CPTU has made available their SOPs on the website here. The SOPs are free to download, but you must first register a valid email and accept the Terms and Conditions for use.
January 2009	The South East Ethics Committee has recenty given a favourable ethical opinion of the LATTE study. The Committee has also agreed that all sites in this study should be exempt from site-specific assessment (SSA) as favourable opinion for the study applies to all sites involved in the research. R&D approval should still be obtained from the relevant care organisation(s) in accordance with NHS research governance arrangements.
December 2008	CPTU will be initiating a new epidemiologic observational study called LATTE in the first quarter of 2009. It will compare the long-term effects of treatment with tamoxifen and anastrozole as adjuvant therapy for breast cancer in post-menopausal women who were in the ATAC trial. There is particular interest in the relative ability of these two treatments to prevent new occurrence of breast canc
December 2008	Following the success of the first two CPTU workshops on Gastrointestinal and Breast cancer prevention and screening, we are planning more workshops for 2009. Details will follow soon.
October 2008	IBIS-II recruitment update - more than 4000 women from 20 countries now enrolled. the IBIS-II target is 10,000.
April 2008	Richard Ostler appointed to UKCRC IS Working Group
December 2007	CPTU awarded full UKCRC Accredited Trials Unit Status
September 2007	IBIS-II recruitment update - nearly 2900 patients from 201 centres in 19 countries
May 2007	The first patient has consented to participate in a new trial looking at preventing endometrial cancer in HNPCC patients (POET)
January 2007	An application for accreditation of the CPTU has been sent to the UKCRC , we should hear back in September